News Updates
More Articles
- Solving the Challenge of Limited Data: Bayesian Statistics to the Rescue in Rare Disease Drug Development
- The Female Data Deficit: How Drug Development Still Fails Women
- China’s Out-Licensing Deals Bear Fruit in 2025
- From Paper to Digital: The Evolution of Electronic Product Information and the LatAm Playbook Experience
- The Hidden Governance Gap in Modern Clinical Trials
Solving the Challenge of Limited Data: Bayesian Statistics to the Rescue in Rare Disease Drug Development
Solving the Challenge of Limited Data: Bayesian Statistics to the Rescue in Rare Disease Drug Development
One concrete example of applying Bayesian statistics is the recent Alzheimer’s approvals by FDA and EMA which utilized this approach for dose-finding.
×
